References
- Ardeshna KM, Pizzey AR, Devereux S, Khwaja A. (2000). The PI3 kinase, p38 SAP kinase, and NF-kappa B signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood 96:1039–46.
- Bachmann MF, Jennings GT. (2010). Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol 10:787–96.
- Banchereau J, Paczesny S, Blanco P, et al. (2003). Dendritic cells: controllers of the immune system and a new promise for immunotherapy. NY Acad Sci 987:180–7.
- Banchereau J, Palucka AK. (2005). Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 5:296–306.
- Baumgartner CK, Malherbe LP. (2010). Regulation of CD4 T-cell receptor diversity by vaccine adjuvants. Immunology 130:16–22.
- Bo RN, Zheng S, Xing J, et al. (2016). The immunological activity of Lycium barbarum polysaccharides liposome in vitro and adjuvanticity against PCV2 in vivo. Int J Biol 85:294–301.
- Broaders KE, Cohen JA, Beaudette TT, et al. (2009). Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy. Proc Natl Acad Sci USA 106:5497–502.
- Danhier F, Ansorena E, Silva JM, et al. (2012). PLGA-based nanoparticles: an overview of biomedical applications. J Control Release 161:505–22.
- De Temmerman ML, Rejman J, Demeester J, et al. (2011). Particulate vaccines: on the quest for optimal delivery and immune response. Drug Discov Today 16:569–82.
- Ding AG, Schwendeman SP. (2008). Acidic microclimate pH distribution in PLGA microspheres monitored by confocal laser scanning microscopy. Pharm Res 25:2041–52.
- Foged C, Brodin B, Frokjaer S, Sundblad A. (2005). Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm 298:315–22.
- Gao W, Fang RH, Thamphiwatana S, et al. (2015). Modulating antibacterial immunity via bacterial membrane–coated nanoparticles. Nano Lett 15:1403–9.
- Gartner LP, Hiatt JL. (2006). Color textbook of histology. 3rd ed. Philadelphia, PA: Elsevier Medicine Publications; Saunders.
- Gomez JMM, Csaba N, Fischer S, et al. (2008). Surface coating of PLGA microparticles with protamine enhances their immunological performance through facilitated phagocytosis. J Control Release 130:161–7.
- Hartgers FC, Figdor CG, (2000), Adema GJ. Towards a molecular understanding of dendritic cell immunobiology. Immunol Today 21:542–5.
- Hsu CL, Chen W, Weng YM, Tseng CY. (2003). Chemical composition, physical properties, and antioxidant activities of yam flours as affected by different drying methods. Food Chem 83:85–92.
- Huang YE, Jiang C, Hu Y, et al. (2013). Immunoenhancement effect of Rehmannia glutinosa polysaccharide on lymphocyte proliferation and dendritic cell. Carbohydr Polym 96:516–21.
- Jusforgues-Saklani H, Uhl M, Blachère N, et al. (2008). Antigen persistence is required for dendritic cell licensing and CD8+ T cell cross-priming. J Immunol 181:3067–76.
- Kim SK, Lee S-C, Shin D-H, et al. (2003). Quantification of endogenous gibberellins in leaves and tubers of Chinese yam, Dioscorea opposita Thunb. cv. Tsukune during tuber enlargement. J Plant Growth Regul 39:125–30.
- Kohli AK, Alpar HO. (2004). Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge. Int J Pharm 275:13–17.
- Langer RS, Peppas NA. (1981). Present and future applications of biomaterials in controlled drug delivery systems. Biomaterials 2:201–14.
- Letsch A, Scheibenbogen C. (2003). Quantification and characterization of specific T-cells by antigen-specific cytokine production using ELISPOT assay for intracellular cytokine staining. Methods 31:143–9.
- Liu ZG, Xing J, Zheng S, et al. (2016). Ganoderma lucidum polysaccharides encapsulated in liposome as an adjuvant to promote Th1-bias immune response. Carbohydr Polym 142:141–8.
- Look M, Saltzman WM, Craft J, Fahmy TM. (2014). The nanomaterial-dependent modulation of dendritic cells and its potential influence on therapeutic immunosuppression in lupus. Biomaterials 35:1089–95.
- Luo L, Zheng SS, Huang YF, et al. (2016). Preparation and characterization of Chinese yam polysaccharide PLGA nanoparticles and their immunological activity. Int J Pharm 511:140–50.
- Mellman I, Steinman RM. (2001). Dendritic cells: specialized and regulated antigen processing machines. Cell 106:255–8.
- Oyewumi MO, Kumar A, Cui ZR. (2010). Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses. Expert Rev Vaccines 9:1095–107.
- Pape KA, Catron DM, Itano AA, Jenkins MK. (2007). The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles. Immunity 26:491–502.
- Pasare C, Medzhitov R. (2005). Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol 560:11–18.
- Park Y, Lee SW, Sung YC. (2002). Cutting edge: CpG DNA inhibits dendritic cell apoptosis by up-regulating cellular inhibitor of apoptosis proteins through the phosphatidylinositide-30-OH kinase pathway. J Immunol 168:5–8.
- Peyre M, Fleck R, Hockley D, et al. (2004). In vivo uptake of an experimental microencapsulated diphtheria vaccine following sub-cutaneous immunization. Vaccine 22:2430–7.
- Randolph GJ, Angeli V, Swartz MA. (2005). Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol 5:617–28.
- Reddy S, Van-Der-Vlies AE, Angeli V, et al. (2007). Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol 25:1159–64.
- Shi Y, Huang G. (2009). Recent developments of biodegradable and biocompatible materials based micro/nanoparticles for delivering macromolecular therapeutics. Crit Rev Ther Drug Carrier Syst 26:29–84.
- Singh M, Chakrapani A, O’Hagan D. (2007). Nanoparticles and microparticles as vaccine-delivery systems. Expert Rev Vaccines 6:797–808.
- Sokolova V, Knuschke T, Kovtun A, et al. (2010). The use of calcium phosphate nanoparticles encapsulating toll-like receptor ligands and the antigen hemagglutinin to induce dendritic cell maturation and T cell activation. Biomaterials 31:5627–33.
- Steinman RM, Hawiger D, Nussenzweig MC. (2003). Tolerogenic dendritic cells. Annu Rev Immunol 21:685–711.
- Storni T, Bachmann MF. (2004). Loading of MHC class I and II presentation pathways by exogenous antigens: a quantitative in vivo comparison. J Immunol 172:6129–35.
- Ulmer JB, Valley U, Rappuoli R. (2006). Vaccine manufacturing: challenges and solutions. Nat Biotechnol 24:1377–83.
- Wykes M, Pombo A, Jenkins C, MacPherson GG. (1998). Dendritic cells interact directly with naïve B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J Immunol 161:1313–19.
- Yang WF, Wang Y, Li XP, Yu P. (2015). Purification and structural characterization of Chinese yam polysaccharide and its activities. Carbohydr Polym 117:1021–7.
- Yuan L, Wu LH, Chen JA, et al. (2010). Paclitaxel acts as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice. Vaccine 28:4402–10.
- Zhao GH, Kan JQ, Li ZX, Chen ZD. (2005). Structural features and immunological activity of a polysaccharide from Dioscorea opposita Thunb roots. Carbohydr Polym 61:125–31.
- Zhang W, Wang L, Liu Y, et al. (2014). Immune responses to vaccines involving a combined antigen–nanoparticle mixture and nanoparticle-encapsulated antigen formulation. Biomaterials 35:6086–97.
- Zhu J, Paul WE. (2008). CD4 T cells: fates, functions, and faults. Blood 112:1557–69.
- Zinkernagel RM. (2003). On natural and artificial vaccinations. Annu Rev Immunol 21:515–546.